122. Superficial siderosis Clinical trials / Disease details

Clinical trials : 3 / Drugs : 3 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000021218	2024/09/30	26/02/2016	Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis (ECHACISS)	Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis (ECHACISS) - ECHACISS	superficial siderosis of CNS	deferiprone administration cochlear implantation	Department of Neurology, Tokyo Medical and Dental University	Department of Neurology, Kouchi University Hospital	Recruiting	20years-old	Not applicable	Male and Female	5	Not applicable	Japan
2	NCT04890808 (ClinicalTrials.gov)	May 2023	12/5/2021	Therapeutic Antioxidant Supplementation	Therapeutic Antioxidant Supplementation for Enhancement of Neural Protection From Free-iron Toxicity in Superficial Siderosis	Superficial Siderosis	Dietary Supplement: Inosine;Dietary Supplement: IP6	Superficial Siderosis Research Alliance Inc.	NULL	Not yet recruiting	16 Years	77 Years	All	50	N/A	NULL
3	JPRN-jRCTs031180438	01/04/2019	27/03/2019	Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis	Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis - ECHACISS	Superficial siderosis siderosis, cerebellar ataxia, hearing loss, superficial siderosis	1. Administration of Deferiprone orally 30mg/kg after every meal for 36 months. 2. Artificial cochlear implantation for severe hearing disturbance	Sanjo Nobuo	NULL	Recruiting	>= 20age old	Not applicable	Both	50	N/A	Japan